Securing this treatment can be a hurdle for many. Currently, it is limited and demands a prescription from a medical provider. Accessing retatrutide typically involves participating in a clinical trial , though anticipated expanded release through traditional pharmaceutical channels is being considered – though a timeframe for this remains undefi